0617 (0617) Fair Value & Analysis

Consumer Cyclical · Market cap HK$179M

0 0617 0617 · HK

PriceHK$0.1610

Fair ValueHK$0.1579

Upside-1.9%

Quality49/100

Evidence: Medium Range HK$0.0894 – HK$0.2684

Fair value as of: Jul 2, 2026

From 10 valuation models · updated today

Share price −19.9% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1610 – HK$0.3900 · fair‑value band HK$0.0894 – HK$0.2684 · the HK$0.1610 price screens above the HK$0.1579 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0617 (0617) currently trades at HK$0.1610, while our model-based Fair Value estimate is HK$0.1579 — implying the stock looks roughly 1.9% overvalued today. We read business quality at 49/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0617 generated revenue of HK$3.8B at a net margin of -30.5%. Revenue grew 94.7% year over year. It earns a return on equity of -14.0%. Net debt stands at HK$18.2B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$3.8B

Revenue growth (YoY) +94.7%

Net margin -30.5%

Return on equity -14.0%

Free cash flow HK$2.0B FY2025

Operating margin -0.8%

More key figures

EPS (TTM) HK$-0.5900

EPS growth (YoY) +129%

Net debt HK$18.2B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0617 reported revenue of HK$3.8B in FY2025 versus HK$4.0B in FY2021, a compound −1.4%/yr. Reported net income was −HK$1.2B in FY2025.

Revenue −1.4%/yr

FY21 HK$4.0B

FY22 HK$4.0B

FY23 HK$2.8B

FY24 HK$2.7B

FY25 HK$3.8B

Net income

FY21 −HK$476M

FY22 −HK$297M

FY23 −HK$1.1B

FY24 −HK$1.6B

FY25 −HK$1.2B

Is 0617 fairly valued? → Check now

Similar stocks

6 more Lodging stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Marriott International, Inc MAR	$384.19	$135.68	-65%
Hilton Worldwide Holdings HLT	$338.15	$103.43	-69%
InterContinental Hotels Group IHG	$170.88	$85.18	-50%
Hyatt Hotels Corporation H	$196.33	$106.17	-46%
H World Group H1TH34	R$62.64	R$59.49	-5%
Accor SA ACRFF	$57.35	$32.74	-43%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0617 (0617) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1579 versus a price of HK$0.1610 — about −2% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0617?

Our model-based fair value for 0617 is HK$0.1579 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1610.

What is the quality score of 0617?

0617 has a Quality Score of 49/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0617 (0617)?

0617 reported trailing-twelve-month revenue of about HK$3.8B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0617?

The net profit margin of 0617 is about -30.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.